About Xenome
Company factsheet
Core values
Leadership
Board of Directors
Management
Discovery Platform
Pipeline
Xen2174
FAQ
Announcements
Company Presentation & Flyers
Scientific Publications & Posters
Latest Announcements
Xenome names Michael Aldridge as Executive Director - 25 May 2010
Xenome Completes A$10M Convertible Note Financing: Ongoing Support from Existing Venture Capital Investors - 22 April 2010
Xenome Licenses Peptides from xdiscover Library to MedImmune - 23 March 2010
©2010 Xenome Ltd ABN 60 081 612 384
Disclaimer
Print
Brisbane | Melbourne | San Diego
